Aclaris Therapeutics Reports Second Quarter 2019 Financial Results, Provides Business Strategy Update and Provides Update on Clinical and Commercial Developments

    NEXT STORY
    Sensus Healthcare Reports Second Quarter 2019 Financial Results
    PREV STORY
    Global $39Bn Cell Analysis Market Forecasts, 2019 to 2025
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Celsion Announces Presentation of OVATION Study Findings at the Upcoming AACR Special Conference

    LAWRENCEVILLE, N.J., Aug. 24, 2017 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ:CLSN), an oncology drug ...

    author_avatar
    NASDAQ Market News

    Global Molecular Diagnostics Market Share & Forecast (2011-2025) by Applications, Technologies, End-users, Regions and Companies

    author_avatar
    NASDAQ Market News

    Lilly Begins a Phase 3 Clinical Trial with Baricitinib for Hospitalized COVID-19 Patients

    author_avatar
    NASDAQ Market News